Viteyes® AREDS 2 formulas are based on the National Eye Institute’s AREDS2 study (Age-Related Eye Disease Study). AREDS 2 is a follow up study to the original AREDS study. The first AREDS study was completed in 2001 and showed that a combination of antioxidants and zinc could help to reduce the risk of progression for macular degeneration by 25% when taking an AREDS formula. The AREDS2 study, completed in 2013, suggests that removing beta-carotene from this formula and adding lutein and zeaxanthin can help to reduce the risk of progression to advanced AMD by 18% compared to the original AREDS formula.
Viteyes® offers a complete line of AREDS 2 based supplements, include Viteyes® AREDS 2, Viteyes® AREDS 2 Plus Omega-3, Viteyes® AREDS 2 Advanced and Viteyes® AREDS 2 Powder (a pill free form). Viteyes® AREDS 2 formulas also contain a lower dose of zinc. “AREDS2 revealed that a formulation providing 25 mg zinc (about one-third the amount in the original AREDS formulation) provided the same protective effect against developing advanced AMD.”*
Viteyes® also provides supplements for other eye health needs, such dry eye and optic nerve health. All Viteyes® formulas are manufactured in the U.S.A. We have created strategic supplier relationships allowing us to provide the best pricing while not sacrificing quality or customer service. Our products use only the highest quality ingredients from top raw material suppliers.
*National Institutes of Health website http://ods.od.nih.gov/factsheets/Zinc-HealthProfessional/